Skip to main content
. 2018 Jun 29;34(5):1116–1124. doi: 10.3904/kjim.2018.011

Figure 1.

Figure 1.

Progression-free survival and overall survival after crizotinib treatment. Kaplan-Meier curves for progression-free survival (A) and overall survival (B) according to training cohort (n = 159) and validation cohort (n = 40) are shown. mPFS, median progression-free survival; CI, confidence interval; HR, hazard ratio; mOS, median overall survival; NR, not reached.